Status:
COMPLETED
EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Pre-eclampsia
Intra-uterine Growth Retardation
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to assess the potential prognostic value of seric concentrations of EG-VEGF for Pre-eclampsia and/or intrauterine growth restriction and will allow checking whether plasma...
Detailed Description
Successful human placentation depends on adequate transformation of the uteroplacental vasculature by extravillous trophoblast (EVT) following proliferation, migration, and invasion of these cells int...
Eligibility Criteria
Inclusion
- Women older than 17 years old
- All pregnant patients enrolled before 14 SG and with singleton, irrespectively of their parity
- Pregnant woman living in the Grenoble area
- Women accepting, the participation to the study.
Exclusion
- Inability to understand the project
- Persons deprived of their liberty by judicial or administrative decisions
- Person under legal protection
Key Trial Info
Start Date :
July 11 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 13 2015
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT01490489
Start Date
July 11 2011
End Date
March 13 2015
Last Update
November 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical investigation center of the Grenoble University Hospital
Grenoble, Isere, France, 38043